Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Ruud P.M. Dings, Emily S.Van Laar, Jeremy Webber, Yan Zhang, Robert J. Griffin, Stephen J. Waters, John R. MacDonald, Kevin H. Mayo

Research output: Contribution to journal › Article › peer-review

41 Scopus citations

Fingerprint

Dive into the research topics of 'Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven'. Together they form a unique fingerprint.

Medicine & Life Sciences